Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Infectious Disease
How do you counsel immunosuppressed patients regarding a third Covid vaccination dose if they have had 2 doses of mRNA vaccine and either pre or post vaccine Covid infection?
Related Questions
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
In a patient with negative Hep B surface Ag, Hep B surface antibody+, and Hep B core antibody+ serologies, do you initiate antiviral prophylaxis (e.g. entecavir) prior to starting rituximab?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
What are your vaccine recommendations while patients are on biologics?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
